Do Statins Have Antidepressant Effects?
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Statins are used widely in primary and secondary prevention of cardiovascular disease; a treatment effect that has long been thought to be due to their cholesterol-lowering properties. However, statins also have a wide range of anti-inflammatory effects independent of their lipid-lowering mechanisms. In depression, low-grade inflammation is a replicated finding, and several studies have shown antidepressant properties of diverse anti-inflammatory drugs. Large observational studies have suggested reduced risks of depression amongst those taking statins, an effect that is thought to be explained by the anti-inflammatory properties of this class of drugs. Also, preliminary randomized controlled trials (RCTs) have indicated that statins may have adjunctive antidepressant effects when used as add-on treatment to selective serotonin reuptake inhibitors (SSRIs). However, the RCTs were small and limited by low generalizability, and some early observational studies have pointed towards potential neuropsychiatric adverse effects of statin treatment. Nevertheless, based on the good tolerability and general safety of the statins, researchers are currently investigating the potential antidepressant properties of these agents. The present review aims to give an overview on the potential antidepressant effects of statins based on their anti-inflammatory properties, covering topics such as safety versus treatment effects, potential mechanisms of action and the possibility of targeted treatme…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Examples include statins, aspirin and angiotensin antagonists.788, 789, 790, 791, 792, 793”
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 15×
“Indeed, in some trials, CRP seemed to be a better biomarker for CVD prevention than low-density lipoprotein cholesterol (LDLC) [46, 50, 51].”
InfluentialOverweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“Depression is a major cause of disability worldwide, but despite state-of-the-art treatment including augmentation strategies, remission rates following antidepressant medications are low [1, 2].”
InfluentialSCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Iso, H., Jacobs, D. R., Wentworth, D., Neaton, J. D., Cohen, J. D., & for the MRFIT Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201405 · Cited by 1,133
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.004 · Cited by 972
Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Self-citationThe macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · cited 1×
“The role of inflammatory processes in the development of depression is the topic that has probably received most attention [17, 18].”
Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1332 · Cited by 846
Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 794
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Jialal, I., Stein, D., Balis, D., Grundy, S. M., Adams-Huet, B., & Devaraj, S. (2001) · Circulation · doi:10.1161/01.cir.103.15.1933 · Cited by 730
Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661
Eggermont, A. M., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Salès, F., Gore, M., MacKie, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61033-8 · Cited by 640
Depression in Rheumatoid Arthritis: A Systematic Review of the Literature With Meta-Analysis
Dickens, C., McGowan, L., Clark-Carter, D., & Creed, F. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200201000-00008 · Cited by 634
Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study
Benros, M. E., Waltoft, B. L., Nordentoft, M., Østergaard, S. D., Eaton, W. W., Krogh, J., & Mortensen, P. B. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1111 · Cited by 572
Self-citationChou, R., Dana, T., Blazina, I., Daeges, M., & Jeanne, T. L. (2016) · JAMA · doi:10.1001/jama.2015.15629 · Cited by 568
Low serum cholesterol and suicide
Engelberg, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90609-7 · Cited by 512
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490
Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 Individuals
Wium-Andersen, M. K., Ørsted, D. D., Nielsen, S. F., & Nordestgaard, B. G. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.102 · Cited by 489
Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin Therapy
Shishehbor, M. H., Aviles, R. J., Brennan, M.-L., Fu, X., Goormastic, M., Pearce, G. L., Gokce, N., Keaney, J. F., Penn, M. S., Sprecher, D. L., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1675 · Cited by 464 · cited 4×
“Also, the antioxidant activities [53] of statins may contribute to this”
InfluentialDahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424 · cited 1×
“• Pro-inflammatory markers have been found at increased levels among depressed individuals compared with healthy controls, independent of somatic illness, particularly C-reactive protein (CRP) [18, 22, 24], interleukin-6 (IL-6) [3, 18, 24, 25], tumour necrosis factor alpha (TNF-a) [3, 25] and interleukin-1 receptor an…”
Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418
Premature mortality from coronary heart disease. The Framingham study
Gordon, T. (1971) · JAMA · doi:10.1001/jama.215.10.1617 · Cited by 387
Innate and adaptive immune responses can be beneficial for CNS repair
Schwartz, M., Moalem, G., Leibowitz-Amit, R., & Cohen, I. R. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01405-8 · Cited by 341
Abbasi, S.-H., Hosseini, F., Modabbernia, A., Ashrafi, M., & Akhondzadeh, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.033 · Cited by 339
Association of high-sensitivity C-reactive protein with de novo major depression
Pasco, J. A., Nicholson, G. C., Williams, L. J., Jacka, F. N., Henry, M. J., Kotowicz, M. A., Schneider, H. G., Leonard, B. E., & Berk, M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076430 · Cited by 321
Self-citationCross-talk between neural stem cells and immune cells: the key to better brain repair?
Kokaia, Z., Martino, G., Schwartz, M., & Lindvall, O. (2012) · Nature Neuroscience · doi:10.1038/nn.3163 · Cited by 320
Inflammation and Specific Symptoms of Depression
Jokela, M., Virtanen, M., Batty, G. D., & Kivimäki, M. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1977 · Cited by 260
Ferro, D., Parrotto, S., Basili, S., Alessandri, C., & Violi, F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00771-3 · Cited by 207
Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link
Korczak, D. J., Pereira, S., Koulajian, K., Matejcek, A., & Giacca, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2240-3 · Cited by 181
A critical review of human endotoxin administration as an experimental paradigm of depression.
DellaGioia, N., & Hannestad, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.014 · Cited by 175 · cited 1×
“• Finally, infusion of cytokines or endotoxins in volunteers is one of the most robust human models of depression [32].”
Berk, M., Dean, O. M., Cotton, S. M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., Schapkaitz, I., et al. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08454 · Cited by 172 · cited 1×
“Several drugs that are primarily used due to their antiinflammatory effects have shown antidepressant effects as well, including aspirin [10, 60], other non-steroidal antiinflammatory drugs (NSAIDs; especially celecoxib [5, 61]), minocycline [62], monoclonal antibodies [63], pioglitazone, N-acetylcysteine and curcumin…”
Self-citationPredictive analytics in mental health: applications, guidelines, challenges and perspectives
Hahn, T., Nierenberg, A. A., & Whitfield, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.201 · Cited by 150
Statins as potential therapeutic agents in neuroinflammatory disorders
Stüve, O., Youssef, S., Steinman, L., & Zamvil, S. S. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000073942.19076.d1 · Cited by 141
Salagre, E., Fernandes, B. S., Dodd, S., Brownstein, D. J., & Berk, M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.047 · Cited by 117 · cited 2×
“Due to the anti-inflammatory properties of statins [7, 8], the antidepressant effects of this class of drugs have also been investigated at epidemiological [9–11], preclinical [12, 13] and clinical [14] levels.”
Self-citationLipid-Lowering Drugs and the Risk of Depression and Suicidal Behavior
Yang, C.-C., Jick, S. S., & Jick, H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.16.1926 · Cited by 115
O'Neil, A. E., Fisher, A. J., Kibbey, K. J., Jacka, F. N., Kotowicz, M. A., Williams, L. J., Stuart, A. L., Berk, M., Lewandowski, P. A., Taylor, C. B., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.029 · Cited by 113
Self-citationAm, E., Suciu, S., Santinami, M., Testori, A., Kruit, W. H. J., Marsden, J. R., Punt, C. J. A., Salès, F., Gore, M. E., MacKie, R., et al. (2008) · Research Explorer (The University of Manchester) · Cited by 111
Statins use and risk of depression: A systematic review and meta-analysis
Parsaik, A. K., Singh, B., M. Hassan, M., Singh, K., Mascarenhas, S. S., Williams, M. D., Lapid, M. I., Richardson, J. W., West, C. P., & Rummans, T. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.026 · Cited by 100 · cited 2×
“It has therefore been argued that larger high-quality observational studies are needed to confirm the above-mentioned findings [9].”
Atopic disorders and depression: Findings from a large, population-based study
Sanna, L., Stuart, A. L., Pasco, J. A., Jacka, F. N., Berk, M., Maes, M. H. J., O'Neil, A. E., Girardi, P., & Williams, L. J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.009 · Cited by 97
Self-citationPharmacogenomics of statins: understanding susceptibility to adverse effects
Kitzmiller, J., Mikulik, E., Dauki, A., Mukherjee, C., & Luzum, J. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s86013 · Cited by 90
Ghanizadeh, A., & Hedayati, A. (2013) · Depression and Anxiety · doi:10.1002/da.22195 · Cited by 81
The impact of statins on psychological wellbeing: a systematic review and meta-analysis
O'Neil, A., Sanna, L., Redlich, C., Sanderson, K., Jacka, F., Williams, L. J., Pasco, J. A., & Berk, M. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-154 · Cited by 78
Self-citationGougol, A., Zareh-Mohammadi, N., Raheb, S., Farokhnia, M., Salimi, S., Iranpour, N., Yekehtaz, H., & Akhondzadeh, S. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115578160 · Cited by 77
Statin use and risk of depression: a Swedish national cohort study
Redlich, C., Berk, M., Williams, L. J., Sundquist, J., Sundquist, K., & Li, X. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0348-y · Cited by 76
Self-citationThe Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study
Köhler, O., Gasse, C., Petersen, L., Ingstrup, K. G., Nierenberg, A. A., Mors, O., & Østergaard, S. D. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15040463 · Cited by 76
Self-citationStatins and biomarkers of inflammation
Devaraj, S., Rogers, J., & Jialal, I. (2007) · Current Atherosclerosis Reports · doi:10.1007/bf02693938 · Cited by 75
Chuang, C., Yang, T.-Y., Muo, C., Su, H., Sung, F., & Kao, C. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.05.008 · Cited by 74
The relationship between statins and depression: a review of the literature
You, H., Lu, W., Zhao, S., Hu, Z., & Zhang, J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.803067 · Cited by 73
Abbasi, S. H., Mohammadinejad, P., Shahmansouri, N., Salehiomran, A., Beglar, A. A., Zeinoddini, A., Forghani, S., & Akhondzadeh, S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.049 · Cited by 70
Kristensen, M. E. L., Christensen, P. M., & Hallas, J. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007118 · Cited by 67
Köhler‐Forsberg, O., Petersen, L. V., Mors, O. N., & Gasse, C. (2015) · Brain and Behavior · doi:10.1002/brb3.338 · Cited by 66
Self-citationStatins of Different Brain Penetrability Differentially Affect CSF PLTP Activity
Vuletic, S., Riekse, R. G., Marcovina, S. M., Peskind, E. R., Hazzard, W. R., & Albers, J. J. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000095679 · Cited by 66
Haghighi, M., Khodakarami, S., Jahangard, L., Ahmadpanah, M., Bajoghli, H., Holsboer-Trachsler, E., & Brand, S. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.018 · Cited by 65
Tuccori, M., Montagnani, S., Mantarro, S., Capogrosso-Sansone, A., Ruggiero, E., Saporiti, A., Antonioli, L., Fornai, M., & Blandizzi, C. (2014) · CNS Drugs · doi:10.1007/s40263-013-0135-1 · Cited by 63
Seventeen Years of Statin Pharmacogenetics: a Systematic Review
Leusink, M., Onland‐Moret, N. C., de Bakker, P. I. W., de Boer, A., & der Zee, A. H. M. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.158 · Cited by 62
Dean, O. M., Maes, M., Ashton, M., Berk, L., Kanchanatawan, B., Sughondhabirom, A., Tangwongchai, S., Ng, C., Dowling, N., Malhi, G. S., et al. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.3.180 · Cited by 58 · cited 1×
“Several drugs that are primarily used due to their antiinflammatory effects have shown antidepressant effects as well, including aspirin [10, 60], other non-steroidal antiinflammatory drugs (NSAIDs; especially celecoxib [5, 61]), minocycline [62], monoclonal antibodies [63], pioglitazone, N-acetylcysteine and curcumin…”
Self-citationAssociations between cardiovascular disease risk factors and IL-6 and hsCRP levels in the elderly
Nadrowski, P., Chudek, J., Skrzypek, M., Puzianowska-Kuźnicka, M., Mossakowska, M., Więcek, A., Zdrojewski, T., Grodzicki, T., & Kozakiewicz, K. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.10.001 · Cited by 53
Sarkar, S., & Schaefer, M. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.06.015 · Cited by 49
Williams, L. J., Bjerkeset, O., Langhammer, A., Berk, M., Pasco, J. A., Henry, M. J., Schei, B., & Forsmo, S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.019 · Cited by 48
Self-citationObesity and the relationship with positive and negative affect
Pasco, J. A., Williams, L. J., Jacka, F. N., Brennan, S. L., & Berk, M. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413483371 · Cited by 48 · cited 1×
“This is despite the fact that statin prescription is associated with cardiovascular comorbidity and known risk factors for depression [71].”
Self-citationFriebe, A., Horn, M., Schmidt, F., Janssen, G., Schmid-Wendtner, M.-H., Volkenandt, M., Hauschild, A., Goldsmith, C. H., & Schaefer, M. (2010) · Psychosomatics · doi:10.1016/s0033-3182(10)70738-6 · Cited by 47
Acute antidepressant and anxiolytic effects of simvastatin and its mechanisms in rats
Kılıç, F. S., Ozatik, Y., Kaygısız, B., Baydemır, C., & Erol, K. (2012) · Neurosciences · doi:10.17712/1658-3183.1914 · Cited by 46
Pharmacogenetic Determinants of Statin-Induced Reductions in C-Reactive Protein
Chu, A. Y., Guilianini, F., Barratt, B. J., Nyberg, F., Chasman, D. I., & Ridker, P. M. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.961847 · Cited by 46
Glueck, C. J., Tieger, M., Kunkel, R., Tracy, T., Speirs, J., Streicher, P., & Illig, E. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90078-r · Cited by 44
Simvastatin treatment exerts antidepressant-like effect in rats exposed to chronic mild stress
Lin, P.-Y., Chang, A. Y. W., & Lin, T.-K. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.06.006 · Cited by 43 · cited 1×
“Due to the anti-inflammatory properties of statins [7, 8], the antidepressant effects of this class of drugs have also been investigated at epidemiological [9–11], preclinical [12, 13] and clinical [14] levels.”
Park, S., Yi, K. K., Na, R., Lim, A., & Hong, J. P. (2013) · Behavioral and Brain Functions · doi:10.1186/1744-9081-9-45 · Cited by 41
Schulz, S., Lüdike, H., Lierath, M., Schlitt, A., Werdan, K., Hofmann, B., Gläser, C., Schaller, H., & Reichert, S. (2016) · Cytokine · doi:10.1016/j.cyto.2016.08.021 · Cited by 40
The use of statins for the treatment of depression in patients with acute coronary syndrome
Kim, S. W., Bae, K. Y., Kim, J. M., Shin, I. S., Hong, Y. J., Ahn, Y., Jeong, M. H., Berk, M., & Yoon, J. S. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.116 · Cited by 38
Self-citationPsychologic Disorders and Statin Use: A Propensity Score‐Matched Analysis
Mansi, I. A., Frei, C. R., Pugh, M. J., & Mortensen, E. M. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1272 · Cited by 38
Simons, J. (2003) · PubMed · Cited by 37
A Prospective Study of Statin Use and Poststroke Depression
Kim, J.-M., Stewart, R., Kang, H.-J., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Kim, J.-T., Park, M.-S., Cho, K.-H., & Yoon, J.-S. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000051 · Cited by 35
Risk of new-onset diabetes associated with statin use
Beckett, R. D., Schepers, S. M., & Gordon, S. K. (2015) · SAGE Open Medicine · doi:10.1177/2050312115605518 · Cited by 35
Köhler, O., Sylvia, L. G., Bowden, C. L., Calabrese, J. R., Thase, M., Shelton, R. C., McInnis, M., Tohen, M., Kocsis, J. H., Ketter, T. A., et al. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416644508 · Cited by 33
Self-citationClinical relevance for lowering C-reactive protein with statins
Arévalo‐Lorido, J. C. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1197413 · Cited by 33
Statin and Aspirin Use and the Risk of Mood Disorders among Men
Williams, L. J., Pasco, J. A., Mohebbi, M., Jacka, F. N., Stuart, A. L., Venugopal, K., O’Neil, A., & Berk, M. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw008 · Cited by 32
Self-citationSelective Serotonin Reuptake Inhibitor Drug Interactions in Patients Receiving Statins
Andrade, C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13f08941 · Cited by 31
Mandas, A., Congiu, M. G., Abete, C., Dessì, S., Manconi, P. E., Musio, M., Columbu, S., & Racugno, W. (2014) · Neurological Research · doi:10.1179/1743132813y.0000000287 · Cited by 27
Ciuculete, D. M., Bandstein, M., Benedict, C., Waeber, G., Vollenweider, P., Lind, L., Schiöth, H. B., & Mwinyi, J. (2016) · Clinical Genetics · doi:10.1111/cge.12890 · Cited by 25
Horsdal, H. T., Olesen, A. V., Gasse, C., Sørensen, H. T., Green, R. C., & Johnsen, S. P. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318180f55b · Cited by 24
Self-citationQuinn, A. L., Dean, O. M., Davey, C. G., Kerr, M., Harrigan, S., Cotton, S., Chanen, A. M., Dodd, S., Ratheesh, A., Amminger, G. P., et al. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12280 · Cited by 21
Self-citationO'Neil, A. E., Fisher, A. J., Kibbey, K. J., Jacka, F. N., Kotowicz, M. A., Williams, L. J., Stuart, A. L., Berk, M., Lewandowski, P. A., Atherton, J. J., et al. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.02.028 · Cited by 17
Self-citationA Genetic Risk Score is Associated with Statin-Induced Low-Density Lipoprotein Cholesterol Lowering
Leusink, M., der Zee, A. H. M., Ding, B., Drenos, F., van Iperen, E. P. A., Warren, H. R., Caulfield, M. J., Cupples, L. A., Cushman, M., Hingorani, A. D., et al. (2016) · Pharmacogenomics · doi:10.2217/pgs.16.8 · Cited by 14
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationWium-Andersen, M. K., Wium-Andersen, I. K., Prescott, E. I. B., Overvad, K., Jørgensen, M. B., & Osler, M. (2020) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.130 · Cited by 87
The concept of violent suicide, its underlying trait and neurobiology: A critical perspective
Ludwig, B., & Dwivedi, Y. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.12.001 · Cited by 62
Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
Moreira, E. G., Boll, K. M., Correia, D. G., Soares, J. F., Rigobello, C., & Maes, M. H. J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x17666181227164947 · Cited by 59
Shared genetic liability between major depressive disorder and osteoarthritis
Zhang, F., Rao, S., & Baranova, A. V. (2022) · Bone and Joint Research · doi:10.1302/2046-3758.111.bjr-2021-0277.r1 · Cited by 58
Metadata
- Authors
- Köhler-Forsberg, O., Gasse, C., Berk, M., & Østergaard, S. D.
- Affiliations
- Aarhus University (DK)
- Deakin University (AU)
- Venue
- CNS Drugs
- Published
- 2017-03-16
- Volume
- 31
- Issue
- 5
- Pages
- 335-343
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- OpenAlex
- W2595471035
- Cited by
- 31
- References
- 101
- Citations by year
- 2026: 3 · 2025: 2 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 5 · 2017: 4
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Scopus (Elsevier) (submittedVersion)
- Funders
- Lundbeckfonden (R155-2014-1724, R165–2013–15320)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- statins, antidepressant effects, depression, anti-inflammatory activity, low-grade inflammation, selective serotonin reuptake inhibitors, neuropsychiatric adverse effects, precision medicine, mechanism of action
- MeSH terms
- Anti-Inflammatory Agents, Non-Steroidal, Antidepressive Agents, Depressive Disorder, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.